Targeting the Trabecular Meshwork: Collaborative Glaucoma Care

This activity is supported by an unrestricted educational grant from New World Medical.

Learning Objectives

Upon completion of this activity, the participant should be able to:

• Identify and understand the advantages and disadvantages of trabecular, supraciliary, and subconjunctival MIGS procedures.
• Describe the efficacy and safety of trabecular and Schlemm canal MIGS procedures.
• Identify the patient characteristics that favor the use of trabecular and Schlemm canal MIGS procedures.
• Adopt optimal surgical techniques when performing trabecular and Schlemm canal MIGS procedures.

Accreditation and Designation Statement

Evolve Medical Education LLC (Evolve) is an approved COPE administrator.

Support by:  
COPE Approved for 0.5 credit hour.
Course Approval # 69688-GL
Activity Approval # 120264

Participation Method

TO OBTAIN CREDIT
To obtain credit for this activity, you must read the activity in its entirety and complete the Pretest/Posttest/Activity Evaluation/Satisfaction Measures Form, which consists of a series of multiple-choice questions.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS

Hardware Requirements:
4GB+ RAM

Recommended internet speed 5Mbps+

Faculty and Disclosures

Michael Greenwood, MD
Cataract, Refractive, Corneal, and Glaucoma Surgeon
Vance Thompson Vision
Fargo, ND

Justin A. Schweitzer, OD, FAAO
Cataract, Cornea, Refractive, and Glaucoma Surgery Specialist
Vance Thompson Vision
Sioux Falls , SD

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Michael Greenwood, MD, and/or spouse had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant and Speakers Bureau: Aerie, Alcon, Allergan, Equinox, Glaukos, Johnson & Johnson Vision, New World Medical, Ocular Therapeutix, STAAR, Sight Sciences, and Zeiss. Grant/Research Support: Alcon, Glaukos, Ocular Therapeutix, Sight Sciences, and STAAR.

Justin A. Schweitzer, OD, FAAO, and/or spouse had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Aerie, Alcon, Allergan, Bausch + Lomb, Glaukos, Johnson & Johnson Vision, Ocular Therapeutix, Reichert, Sight Sciences, and Sun Pharma. Speaker’s Bureau: Aerie, Alcon, Allergan, Bausch + Lomb, Glaukos, and Johnson & Johnson Vision. Share/Stockholder: Equinox.

The Evolve staff and planners have no financial relationships with commercial interests. Virginia Pickles, writer, and Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Modern Optometry, or New World Medical.